A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

Clinical trial NCT06697197 · RECRUITING

Trial details

NCT number: NCT06697197
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-02-17
Primary completion: 2029-01-04
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.